April 13, 2016

Biologic medications — nine of which were among the Food and Drug Administration’s approvals in 2015 — constitute a big portion of the specialty market.

April 13, 2016

The legislation, advocated by both retail pharmacy and the pharma industry, would advance collaboration among health and enforcement authorities to achieve drug abuse solutions that maintain patients’ legitimate access to medications.

April 13, 2016

It’s no secret that the category of drugs drawing the most attention — and money — in recent years has been specialty pharmacy.

April 12, 2016

A new report from Accenture is shedding light on a new focus on the part of pharmaceutical companies: investing in patient-centered capabilities and services.

April 12, 2016

The company said it uses web-based pharmacy benefit system MERLIN, which has 16 integrated modules that can aid in personalizing service for each client.

April 11, 2016

Mike Kelly has been in the industry for almost 30 years, and joins Adapt Pharma— maker of Narcan Nasal Spray (naloxone HCl) — from Covis Pharmaceuticals, where he was CEO and a member of its board. 

April 11, 2016

California pharmacists are authorized to furnish oral, transdermal, vaginal and Depo injection forms of prescription birth control under a new law that took effect April 8. 

April 11, 2016

AbbVie’s Venclexta received priority review, accelerated approval and the breakthrough therapy designation from the FDA. 

April 11, 2016

When implementation of Walgreens' naloxone program is complete, naloxone will be available without a prescription in more than 5,800 of Walgreens nearly 8,200 stores.

April 7, 2016

The letter points out that copay increases place financial burdens on TRICARE beneficiaries and restrict patient access. In addition, restricting patient access could adversely impact medication compliance and actually increase health costs. 

April 6, 2016

The combined company would bring to market oncology therapies, men’s and women’s health therapeutics and consumer health products. 

April 6, 2016

Hospira, now a Pfizer company, entered into an agreement with Celltrion and Celltrion Healthcare in 2009 for several potential biosimilar products, including the recently-approved Inflectra.

April 6, 2016

In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.

April 5, 2016

The partnership is aimed at accelerating several of CutisPharma's products in development toward FDA approval. 

April 5, 2016

Descovy has a similar antiviral efficacy to Gilead’s Viread (tenofovir disoproxil fumarate), but contains one-tenth the dose of tenofovir as Viread, the company said. 

April 4, 2016

The study found that Walgreens pharmacy patients who used a multi-faceted medication adherence program had a 3% higher medication adherence rate and lower healthcare costs than those who use other pharmacies.

April 1, 2016

However, flu activity is still relatively high across Wyoming, Montana and Kentucky, according to the report. 

April 1, 2016
The report attributes the growth to a concurrent increase in chronic pain in the United States, stemming from an aging population and more incidences of such chronic diseases as diabetes, obesity, cancer, arthritis and cardiovascular disease. 
April 1, 2016

WHIPPANY, N.J. - Other pharma companies may focus on foreign market opportunities, but the key strategy driving growth at Bayer is its commitment to innovating the U.S. marketplace, The Herald reported Friday. "[Bayer] is also creating new products just for the U.S., like TruBiotics immune supplement and Aleve PM and over-the-counter versions of some prescription drugs," noted AP reporter Linda Johnson. "Erik Gordon, an assistant professor at University of Michigan's Ross School of Business, said Bayer can raise U.S. sales significantly with its larger product lineup and increased marketing. Meanwhile, its metamorphosis to a pure life sciences company should boost research productivity." (The Herald

March 31, 2016

The complaint alleges that Endo paid Impax Laboratories and Watson Laboratories, which were the first companies to file for FDA approval for generics of Endo’s Opana ER and Lidoderm, to delay their generic product launches. 

March 30, 2016

Recognizing that an estimated 40% of sold medications end up unused, the Alliance for Aging Research's latest “pocket film” offers consumers a simple step-by-step guide on safe disposal. 

March 29, 2016

By 2020, the biosimilars market will grow to $390 billion and the patents on eight biologic drugs will expire.

March 29, 2016

Russia Beyond the Headlines is reporting that in Russia, following the news in early March that tennis star Maria Sharapova tested positive for meldonium, sales of the drug — which costs about $4 to $5 (300 rubles) and which many pharmacies sell without a prescription — have risen dramatically. According to the report, many of those buying the drug are amateur athletes. (RBTH)

March 28, 2016

Last month, the CDC reported preliminary overall influenza vaccine effectiveness of 59% this season.